Adalimumab (Humira) and Infliximab (Remicade)
Why does the CAA disqualify these two medications? It seems the UK CAA are very good at telling you what is and isn't allowed, but doesn't explain the reasons why in a significant number of cases. Both medications can make some people sleepy, but that's nearly always only on the day of administration (once every two weeks for Humira, once every 1-2 months for Remicade). I don't really understand how this is debilitating enough to warrant disqualification.